Randomized, Crossover Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Characterized by Low Tear Volume

Trial Profile

Randomized, Crossover Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Characterized by Low Tear Volume

Discontinued
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2017

At a glance

  • Drugs SHP-659 (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Sponsors Parion Sciences
  • Most Recent Events

    • 02 Jun 2017 Status changed from recruiting to discontinued.
    • 03 Oct 2016 Status changed from not yet recruiting to recruiting.
    • 01 Jul 2016 Status changed from planning to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top